Lexeo TherapeuticsLXEO
那斯達克 · USD
4.13
-0.11
(-2.59%)
收盤 06/11 03:59 (UTC+8)
06/11 03:59 (UTC+8)
Lexeo TherapeuticsLXEO
4.13
-0.11
(-2.59%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 22,333 | 23,116 | 21,648 | 30,688 | 33,805 | 27,382 | 31,543 | 23,550 | 23,291 | 14,974 |
研發費用 | 15,703 | 16,210 | 15,695 | 14,721 | 17,171 | 18,366 | 23,423 | 16,560 | 15,742 | 8,210 |
推銷及管理費用 | 6,630 | 6,906 | 5,953 | 15,967 | 16,634 | 9,016 | 8,120 | 6,990 | 7,549 | 6,764 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -22,333 | -23,116 | -21,648 | -30,688 | -33,805 | -27,382 | -31,543 | -23,550 | -23,291 | -14,974 |
其他收入及費用 | 2,154 | 2,217 | 1,387 | 4,610 | 1,177 | 1,488 | 2,089 | 2,347 | 1,646 | 837 |
利息費用 | 17 | 20 | 22 | 25 | 28 | 30 | 35 | 35 | 37 | 50 |
稅前純益 | -20,196 | -20,919 | -20,283 | -26,103 | -32,656 | -25,924 | -29,489 | -21,238 | -21,682 | -14,187 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -20,196 | -20,919 | -20,283 | -26,103 | -32,656 | -25,924 | -29,489 | -21,238 | -21,682 | -14,187 |
基本每股稅後盈餘(元) | -0.25 | -0.27 | -0.33 | -0.60 | -0.99 | -0.79 | -0.89 | -0.64 | -0.77 | - |
稀釋每股稅後盈餘(元) | -0.25 | -0.14 | -0.19 | -0.54 | -0.99 | -0.78 | -0.90 | -0.64 | -0.77 | 19.84 |
基本平均股數(千股) | 81183.00 | 76356.00 | 60980.00 | 43573.00 | 33113.00 | 33106.00 | 33063.00 | 33001.00 | 27979.00 | - |
稀釋平均股數(千股) | 81183.00 | 76356.00 | 60980.00 | 43573.00 | 33113.00 | 33106.00 | 33063.00 | 33001.00 | 27979.00 | - |
還原基本每股稅後盈餘(元) | -0.25 | -0.27 | -0.33 | -0.60 | -0.99 | -0.79 | -0.89 | -0.64 | -0.77 | - |
還原稀釋每股稅後盈餘(元) | -0.25 | -0.14 | -0.19 | -0.54 | -0.99 | -0.78 | -0.90 | -0.64 | -0.77 | 19.84 |
還原基本平均股數(千股) | 81,183 | 76,356 | 60,980 | 43,573 | 33,113 | 33,106 | 33,063 | 33,001 | 27,979 | - |
還原稀釋平均股數(千股) | 81,183 | 76,356 | 60,980 | 43,573 | 33,113 | 33,106 | 33,063 | 33,001 | 27,979 | - |
EBITDA(千元) | -20,148 | -20,821 | -20,128 | -25,982 | -32,556 | -25,842 | -29,371 | -21,126 | -21,576 | -14,060 |